BusinessVoyager Therapeutics Reports Fourth Quarter and Full Year 2017 Financial ResultsBy Nasdaq OMXMar 14, 2018, 11:02 AM UTC
BusinessVoyager Therapeutics and AbbVie Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimer’s Disease and Other Tau-Related Neurodegenerative DiseasesBy Nasdaq OMXFeb 20, 2018, 12:01 PM UTC
BusinessINVESTORS SAY EXECUTIVE PAY PACKAGES AT PHARMA MAY INCENTIVIZE DRUG PRICING RISKSBy Nasdaq OMXDec 13, 2017, 6:13 PM UTC
BusinessAgile Therapeutics to Present Additional Phase 3 Data at the 2017 Annual Clinical and Scientific Meeting of the American Congress of Obstetricians and GynecologistsBy Nasdaq OMXMay 3, 2017, 8:15 PM UTC
BusinessAgile Therapeutics Receives Approximately $3 Million in Non-Dilutive Funding from New Jersey’s Technology Business Tax Certificate Transfer ProgramBy Nasdaq OMXDec 1, 2016, 1:00 PM UTC
